{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:47:30Z","timestamp":1792097250100,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003976","name":"Israel National Institute for Health Policy Research","doi-asserted-by":"publisher","award":["2025\/88"],"award-info":[{"award-number":["2025\/88"]}],"id":[{"id":"10.13039\/501100003976","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.amjmed.2026.09.006","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:15:48Z","timestamp":1789661748000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Calcium channel blockers are safe and beneficial in patients with heart failure and advanced chronic kidney disease"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6235-4031","authenticated-orcid":false,"given":"Viana","family":"Copeland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-0336","authenticated-orcid":false,"given":"Assi","family":"Milwidsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3463-0457","authenticated-orcid":false,"given":"Shir","family":"Elimeleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Makmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranel","family":"Loutati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7628-8889","authenticated-orcid":false,"given":"Moti","family":"Zwilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8063-2806","authenticated-orcid":false,"given":"Yishay","family":"Wasserstrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6653-7543","authenticated-orcid":false,"given":"Amitai","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elad","family":"Maor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2026.09.006_bib0001","article-title":"Conference participants. Kidney disease and heart failure: recent advances and current challenges: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies Conference","author":"Lam","year":"2026","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.amjmed.2026.09.006_bib0002","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.3390\/ijms24032988","article-title":"Chronic kidney disease as a comorbidity in heart failure","volume":"24","author":"Szlagor","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.amjmed.2026.09.006_bib0003","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfaf128","article-title":"Advanced chronic kidney disease coexisting with heart failure: navigating patients' management","volume":"18","author":"Zoccali","year":"2025","journal-title":"Clin Kidney J"},{"issue":"18","key":"10.1016\/j.amjmed.2026.09.006_bib0004","first-page":"e895","article-title":"ACC\/AHA Joint Committee members. 2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"4S","key":"10.1016\/j.amjmed.2026.09.006_bib0005","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.amjmed.2026.09.006_bib0006","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s40256-024-00641-9","article-title":"Drug therapy for acute and chronic heart failure with preserved ejection fraction with hypertension: a State-of-the-art review","volume":"24","author":"Hiraiwa","year":"2024","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.amjmed.2026.09.006_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejim.2023.10.008","article-title":"The current best drug treatment for hypertensive heart failure with preserved ejection fraction","volume":"120","author":"Rist","year":"2024","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.amjmed.2026.09.006_bib0008","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/eurjpc\/zwac004","article-title":"Associations between calcium channel blocker therapy and mortality in heart failure with preserved ejection fraction","volume":"29","author":"Wang","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.006_bib0009","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/CIRCHEARTFAILURE.114.001301","article-title":"Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction","volume":"7","author":"Patel","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.amjmed.2026.09.006_bib0010","article-title":"Effects of calcium channel blockers in patients with heart failure with preserved and mildly reduced ejection fraction: a systematic review and meta-analysis","volume":"55","author":"Fukuta","year":"2024","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"23","key":"10.1016\/j.amjmed.2026.09.006_bib0011","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"10022","key":"10.1016\/j.amjmed.2026.09.006_bib0012","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.amjmed.2026.09.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102265","article-title":"Improved survival in octogenarians with heart failure: 15-year cohort study from a national referral center","volume":"4","author":"Copeland","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.amjmed.2026.09.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2026.103005","article-title":"Frailty redefines risk across the weight spectrum in heart failure","volume":"14","author":"Copeland","year":"2026","journal-title":"JACC Heart Fail"},{"issue":"36","key":"10.1016\/j.amjmed.2026.09.006_bib0015","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.006_bib0016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ehf2.14576","article-title":"Calcium channel blockers and clinical outcomes in patients with continuous-flow left ventricular assist devices","volume":"11","author":"Tie","year":"2024","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.amjmed.2026.09.006_bib0017","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"issue":"18","key":"10.1016\/j.amjmed.2026.09.006_bib0018","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/eurheartj\/ehy811","article-title":"CLARIFY investigators. \u0392-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study","volume":"40","author":"Sorbets","year":"2019","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.amjmed.2026.09.006_bib0019","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10741-020-10069-3","article-title":"Management of RAASi-associated hyperkalemia in patients with cardiovascular disease","volume":"26","author":"Silva-Cardoso","year":"2021","journal-title":"Heart Fail Rev"},{"issue":"10","key":"10.1016\/j.amjmed.2026.09.006_bib0020","article-title":"Calcium channel blockers for people with chronic kidney disease requiring dialysis","volume":"10","author":"Mugendi","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.amjmed.2026.09.006_bib0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cardfail.2022.09.013","article-title":"Managing heart failure in patients on dialysis: state-of-the-art review","volume":"29","author":"Khan","year":"2023","journal-title":"J Card Fail"},{"key":"10.1016\/j.amjmed.2026.09.006_bib0022","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist versus a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The international verapamil-trandolapril study (INVEST): a randomized controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"Jama"},{"key":"10.1016\/j.amjmed.2026.09.006_bib0023","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/ki.1996.480","article-title":"Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy","volume":"50","author":"Bakris","year":"1996","journal-title":"Kidney Int"},{"issue":"9","key":"10.1016\/j.amjmed.2026.09.006_bib0024","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"30","key":"10.1016\/j.amjmed.2026.09.006_bib0025","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/eurheartj\/ehy301","article-title":"Heart failure with preserved ejection fraction: from mechanisms to therapies","volume":"39","author":"Lam","year":"2018","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.amjmed.2026.09.006_bib0026","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","article-title":"Evaluation and management of heart failure with preserved ejection fraction","volume":"17","author":"Borlaug","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjmed.2026.09.006_bib0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.me.41.020190.001445","article-title":"Effects of calcium channel blockers on renal function","volume":"41","author":"Chan","year":"1990","journal-title":"Annu Rev Med"},{"issue":"17","key":"10.1016\/j.amjmed.2026.09.006_bib0028","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"PARAGON-HF investigators and committees. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2026.09.006_bib0029","article-title":"Effect of amlodipine on morbidity and mortality in severe chronic heart failure","volume":"335(15)","author":"Packer","year":"1996","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432600673X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293432600673X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:34:49Z","timestamp":1792096489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293432600673X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S000293432600673X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.09.006","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium channel blockers are safe and beneficial in patients with heart failure and advanced chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}